中药、天然药物治疗女性更年期综合征临床研究技术指导原则

2019-10-31 国家药品监督管理局药品审评中心(CDE)

中药、天然药物治疗女性更年期综合征临床研究技术指导原则

中文标题:

中药、天然药物治疗女性更年期综合征临床研究技术指导原则

发布日期:

2019-10-31

简要介绍:

中药、天然药物治疗女性更年期综合征临床研究技术指导原则

相关资料下载:
[AttachmentFileName(sort=100, fileName=中药、天然药物治疗女性更年期综合征临床研究技术指导原则)] GetToolGuiderByIdResponse(projectId=1, id=315a11c0018136cd, title=中药、天然药物治疗女性更年期综合征临床研究技术指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=中药、天然药物治疗女性更年期综合征临床研究技术指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Thu Oct 31 04:45:36 CST 2019, originalUrl=, linkOutUrl=, content=中药、天然药物治疗女性更年期综合征临床研究技术指导原则, tagList=[TagDto(tagId=52780, tagName=更年期综合征)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2146, appHits=192, showAppHits=11, pcHits=1050, showPcHits=1490, likes=40, shares=6, comments=3, approvalStatus=1, publishedTime=Thu Oct 31 04:45:36 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 04:45:36 CST 2019, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 19:43:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中药、天然药物治疗女性更年期综合征临床研究技术指导原则)])
中药、天然药物治疗女性更年期综合征临床研究技术指导原则
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954618, encodeId=343b954618d6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:16:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894244, encodeId=a5f589424498, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d8e1609469, createdName=yphoenix, createdTime=Sun Oct 25 09:03:15 CST 2020, time=2020-10-25, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好,但无法分享,遗憾!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954618, encodeId=343b954618d6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:16:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894244, encodeId=a5f589424498, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d8e1609469, createdName=yphoenix, createdTime=Sun Oct 25 09:03:15 CST 2020, time=2020-10-25, status=1, ipAttribution=)]
    2020-10-25 yphoenix

    学习

    0